輸入代號或公司名稱後按 Enter
4192

杏國

-0.65 (-3.44%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
18.255成交張數本益比2.93股價淨值比0.00%殖利率2026-09-11資料日期

毛利率、營業利益率、淨利率

單季;近十年

單季營收

億元

季度營收(億)營收年增毛利(億)毛利率營業利益(億)營業利益率淨利率
2026Q20.1-19.7%0.068.4%-0.1-219.7%-214.5%
2026Q10.113.7%0.064.0%-0.1-219.0%-211.9%
2025Q40.111.9%0.176.4%-0.1-175.0%-167.8%
2025Q30.122.3%0.1116.1%-0.1-135.2%-124.3%
2025Q20.110.3%0.059.6%-0.1-152.2%-149.5%
2025Q10.123.0%0.060.9%-0.1-253.6%-253.6%
2024Q40.16.6%0.055.1%-0.1-222.4%-197.8%
2024Q30.1-8.6%0.056.9%-0.1-269.0%-271.9%
2024Q20.156.5%0.048.1%-0.1-204.3%-190.5%
2024Q10.018.2%0.064.8%-0.1-329.1%-305.5%
2023Q40.121.3%-0.1-121.1%0.3533.3%673.6%
2023Q30.129.0%0.059.5%-0.3-482.6%-509.3%
2023Q20.055.2%0.056.5%-0.3-567.8%-583.1%
2023Q10.010.2%0.054.1%-0.2-670.4%-646.0%
2022Q40.177.5%0.061.2%-0.8-1619.0%-1604.6%
2022Q30.0203.0%0.057.3%-0.3-561.9%-682.2%
2022Q20.0128.6%0.052.7%-0.4-1385.1%-1164.6%
2022Q10.0156.1%0.055.3%-0.4-1291.0%-1260.1%
2021Q40.0-49.3%0.054.3%-0.8-2839.8%-2792.2%
2021Q30.0-62.4%0.013.2%-2.2-14879.5%-14773.8%
2021Q20.0-23.0%0.049.5%-0.8-6518.0%-6915.7%
2021Q10.0-36.9%0.044.5%-0.7-5615.5%-5450.5%
2020Q40.1166.4%0.053.8%-1.0-1782.3%-1812.5%
2020Q30.092.8%0.039.9%-1.0-2547.1%-2593.8%
2020Q20.0-28.8%0.042.5%-1.1-6596.4%-6618.7%
2020Q10.0-67.8%0.041.8%-0.9-4091.2%-4060.1%
2019Q40.010.3%0.040.0%-1.2-5447.5%-5280.8%
2019Q30.01.6%0.041.2%-1.1-5529.1%-5433.3%
2019Q20.019.7%0.045.0%-1.2-5314.8%-5238.3%
2019Q10.1254.8%0.185.4%-0.6-992.0%-981.6%
2018Q40.0-3.0%0.054.7%-1.0-5056.8%-4784.9%
2018Q30.0-1.9%0.046.8%-0.8-4052.1%-4026.7%
2018Q20.0-14.6%0.055.0%-0.7-3621.6%-3551.6%
2018Q10.0-0.4%0.055.0%-0.5-2833.9%-2845.8%
2017Q40.0-0.9%0.055.0%-0.7-3391.1%-3405.6%
2017Q30.025.9%0.052.3%-0.7-3216.3%-3140.4%
2017Q20.026.9%0.046.7%-0.7-2927.6%-2764.4%
2017Q10.024.4%0.046.2%-0.6-3280.3%-3442.9%
2016Q40.00.046.8%-0.7-3513.0%218.3%
2016Q30.00.046.6%-0.6-3503.9%-3400.1%